2018-11-05
Wang Mei-Hua, Vice Minister of Economic Affairs, led the “Taiwan-Europe Bilateral Investment Technology Cooperation Delegation" to Germany, Denmark, and the United Kingdom from October 27 to November 2 to advance industrial investment cooperation and attract investment. The delegation visited 8 key foreign companies in the optoelectronics and semiconductors, smart machinery, biotechnology and pharmaceuticals, offshore wind power and aviation industries and promoted multiple investment and technology cooperation projects. It also signed a letter of intent (LOI) for investment with the international pharmaceuticals company that ranks first in the world in innovation. The delegation was also invited to exchange opinions on Taiwan and the development of the global circular economy with the Cross-Party Group on Taiwan in the Scottish Parliament. The important achievements of the delegation are as follows:
1. Advancement of optoelectronics, semiconductors and smart manufacturing supply chain in Taiwan: The delegation visited Manz AG, the German high-tech equipment manufacturer and facilitated expansion of next-generation laser cutting and corrosion and human-machine integration technologies based on the company’s foundations for semiconductor wet process equipment manufacturing technologies in Taiwan. The investment will help Taiwan accumulate comprehensive innovation capacity in the optoelectronics and semiconductor equipment manufacturing sector. In addition, the delegation also visited the world-leading pump manufacturer and R&D company Grundfos in Denmark and encouraged the company to continue expansion in Miaoli as well as to conduct technology cooperation with domestic companies in waste water treatment and smart pumps.
2. Advancement of local development in the offshore wind power industry: The advancement of the offshore wind power industry is a key task in Taiwan’s energy transition. Taiwan has selected 7 offshore wind farm developers in the first half of this year. To continue to strengthen weaknesses in domestic production supply chain for Taiwan’s offshore wind power, the delegation focused on European firms that specialize in the production of wind turbines, marine engineering, and other advanced offshore wind power industries. It visited the Danish company MVOW and encouraged the company to establish a nacelle assembly plant or gear box manufacturing plant in Taiwan. The delegation also visited WindHoist, a British company that specializes in installation and logistics for wind turbine installation, and encouraged the company to establish a branch company in Taiwan, form a technical team with domestic suppliers, establish a personnel training center, and help cultivate technical personnel for wind turbine installation. In addition, the delegation also visited the Scottish energy conglomerate Woods Group and encouraged the company to establish a branch company in Taiwan. Woods Group shall comply with Taiwan’s domestic production policies and work with Taiwanese suppliers to expedite technology upgrade and help Taiwan set up a wind turbine industrial chain.
3. Encouraging international pharmaceuticals companies to invest in preliminary R&D of new drugs in Taiwan: The delegation visited the British biochip manufacturer Arrayjet and encouraged the company to commence technology collaboration with Taiwanese ICT and precision manufacturing industries. The delegation also visited AstraZeneca, the British pharmaceuticals manufacturer that ranked first in the world for innovation. Vice Minister Wang Mei-Hua and the company’s Vice President Ms. Rene van der Merwe represented the Ministry and AstraZeneca in signing a letter of intent (LOI) for investment. The Company has operated in Taiwan for more than 70 years. In addition to tripling its clinical research budget in Taiwan in recent years and facilitating the launch of 10 new drugs, the company also announced during the visit that it shall establish the iDream innovation center in Taiwan to cultivate innovative technologies and talents for preliminary R&D in the pharmaceuticals industry in Taiwan. It shall also use Taiwan as the company’s advancement center for the iDream project in Asia which is expected to become a pilot program for powering large international pharmaceuticals companies’ investment in preliminary drug R&D in Taiwan.
Members of the delegation, whose mission was to facilitate actual investment and technical collaboration, included representatives of the Department of Investment Services, Industrial Development Bureau, Biotechnology and Pharmaceutical Industries Promotion Office, Metal Industries Research & Development Centre, Green Energy and Environment Research Laboratories of Industrial Technology Research Institute, and Biomedical Technology and Device Research Laboratories. The MOEA will continue to focus on major industries, target overseas Taiwanese and foreign key technology investors, promote investment in Taiwan, advance industry upgrading and transition, and strengthen overall economic prosperity and growth.
Department of Investment Services Spokesperson: Chang Yuan-Chih, Senior Executive Officer
Office Number: 02-2389-2111 ext. 812
Mobile Phone: 0937-013-690
Email address: [email protected]
Contact Person: Lin Mei-Hsing, Section Chief
Office Number: 02-2389-2111 ext. 212
Mobile Phone: 0988-158-298
Email address: [email protected]
Source： Department of Investment Services, Ministry of Economic Affairs
About Us
InvesTaiwan InvesTaiwan Service Center Department of Investment Promotion, MOEA Department of Investment Review, MOEA Contact TaiwanWhy Taiwan
Reasons to Invest Overview Key Industries for Investment Promotion Incentives Important Policies Success Stories
MOEA
MOEA DOIP
MOEA YouTube
Let's Juiker Together
